Company / CapEx per Share
Mirum Pharmaceuticals, Inc. CapEx per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2025
5-year range
$0.00 / $0.02
FY2021-FY2025
Trend
-7.1%
vs FY2024
Sector context
#107 of 192
Health Care
What the data says
At $0.02, Mirum Pharmaceuticals, Inc.'s capex per share ranks #107 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 8 years, ranging from $0.00 in FY2018 to $0.02 in FY2019.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of +17.2%.
Improved from $0.00 to $0.02 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +193.0%
- 5-Year CAGR
- +17.2%
- 10-Year CAGR
- -
Sector benchmark
#107 of 192 in Health CareTop 56% of 192This company $0.02 Sector average $2.46
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 7.1% year-over-year.
- Ranks #107 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2019.
- Lowest capex per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -7.1% |
| FY2024 | $0.02 | +620.6% |
| FY2023 | $0.00 | +275.8% |
| FY2022 | $0.00 | -89.6% |
| FY2021 | $0.01 | -15.2% |
| FY2020 | $0.01 | -63.6% |
| FY2019 | $0.02 | - |
| FY2018 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026